Changchun BCHT Biotechnology Co.

SHSE:688276 Stock Report

Market Cap: CN¥9.8b

Changchun BCHT Biotechnology Balance Sheet Health

Financial Health criteria checks 6/6

Changchun BCHT Biotechnology has a total shareholder equity of CN¥4.2B and total debt of CN¥62.6M, which brings its debt-to-equity ratio to 1.5%. Its total assets and total liabilities are CN¥5.3B and CN¥1.1B respectively. Changchun BCHT Biotechnology's EBIT is CN¥450.1M making its interest coverage ratio -96.5. It has cash and short-term investments of CN¥277.9M.

Key information

1.5%

Debt to equity ratio

CN¥62.58m

Debt

Interest coverage ratio-96.5x
CashCN¥277.89m
EquityCN¥4.20b
Total liabilitiesCN¥1.11b
Total assetsCN¥5.31b

Recent financial health updates

Changchun BCHT Biotechnology (SHSE:688276) Seems To Use Debt Quite Sensibly

Jan 03
Changchun BCHT Biotechnology (SHSE:688276) Seems To Use Debt Quite Sensibly

Is Changchun BCHT Biotechnology (SHSE:688276) Using Too Much Debt?

Jun 19
Is Changchun BCHT Biotechnology (SHSE:688276) Using Too Much Debt?

Recent updates

Changchun BCHT Biotechnology (SHSE:688276) Seems To Use Debt Quite Sensibly

Jan 03
Changchun BCHT Biotechnology (SHSE:688276) Seems To Use Debt Quite Sensibly

Market Might Still Lack Some Conviction On Changchun BCHT Biotechnology Co. (SHSE:688276) Even After 36% Share Price Boost

Oct 07
Market Might Still Lack Some Conviction On Changchun BCHT Biotechnology Co. (SHSE:688276) Even After 36% Share Price Boost

Analysts Just Slashed Their Changchun BCHT Biotechnology Co. (SHSE:688276) EPS Numbers

Aug 22
Analysts Just Slashed Their Changchun BCHT Biotechnology Co. (SHSE:688276) EPS Numbers

Changchun BCHT Biotechnology Co. (SHSE:688276) Doing What It Can To Lift Shares

Jul 28
Changchun BCHT Biotechnology Co. (SHSE:688276) Doing What It Can To Lift Shares

Is Changchun BCHT Biotechnology (SHSE:688276) Using Too Much Debt?

Jun 19
Is Changchun BCHT Biotechnology (SHSE:688276) Using Too Much Debt?

Changchun BCHT Biotechnology Co. (SHSE:688276) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless

Apr 16
Changchun BCHT Biotechnology Co. (SHSE:688276) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless

We Think That There Are Issues Underlying Changchun BCHT Biotechnology's (SHSE:688276) Earnings

Mar 30
We Think That There Are Issues Underlying Changchun BCHT Biotechnology's (SHSE:688276) Earnings

Financial Position Analysis

Short Term Liabilities: 688276's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥1.1B).

Long Term Liabilities: 688276's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥47.1M).

Debt to Equity History and Analysis

Debt Level: 688276 has more cash than its total debt.

Reducing Debt: 688276's debt to equity ratio has reduced from 18.6% to 1.5% over the past 5 years.

Debt Coverage: 688276's debt is well covered by operating cash flow (582.5%).

Interest Coverage: 688276 earns more interest than it pays, so coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 13:56
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Changchun BCHT Biotechnology Co. is covered by 12 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hangci ZhengChina International Capital Corporation Limited
Yizheng YangChina International Capital Corporation Limited
Sophia ZhangChina Stock Investment Research Co. Ltd. (GZ500..com)